# Conmind

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/conmind

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.conmindmed.com
- Total disclosed funding: $29M
- Latest round: Series C (Apr 7, 2026)
- Investors on record: 5

## About

Based in Shenzhen, China and founded in 2020, Conmind operates as a medical device manufacturer specializing in cardiovascular interventional medical devices. There are more than 200 employees in the company. The CEO of the company, Hui Huang, was the director of Marketing at HMSJ. In September 2022, 4 neurointerventional pathway-based products approved by NMPA. In December 2022, it was recognized as a national high-tech enterprise. The company obtained ISO13485 medical device quality management system certification in May 2023. In April 2026, Conmind closed nearly CNY 200 million in Series C funding led by Zhongshan Venture Capital, with participation from Yuecai Ventures, Guangdong Technology Financial Group, King Tower Capital Group, Jinhang Qiying Fund, Zhuhai Hi-tech Venture Capital.

Conmind’s neurointerventional product pipeline focuses on holistic aneurysm treatment solutions, and its cardiac interventional products focus on mitral and tricuspid valve interventional repair areas. The products manufactured by the company include HaloChord® Interventional Mitral Tendon Cord Repair System, J-Tube™ Flow-Directed Mesh Stent, Campsis™ Microcatheter, Thatch™ Microguidewire, Cycas™ Distal Embolic Protection System, Crassula™ Intracranial Spring Coil Embolization System, and Fringe® Support Catheter.

The company generates revenue from the sales of cardiovascular interventional medical devices.

## Funding rounds

- Series C, Apr 7, 2026, $29M — Guangdong Technology Financial Group, Zhuhai Hi-tech Venture Capital, Yuecai Ventures, Zhongshan Venture Capital, King Tower Capital Group

## Investors

- Guangdong Technology Financial Group (https://capitalatlas.ai/funds/guangdong-technology-financial-group) — Series C
- Zhuhai Hi-tech Venture Capital (https://capitalatlas.ai/funds/zhuhai-hi-tech-venture-capital) — Series C
- Yuecai Ventures (https://capitalatlas.ai/funds/yuecai-ventures) — Series C
- Zhongshan Venture Capital (https://capitalatlas.ai/funds/zhongshan-venture-capital) — Series C
- King Tower Capital Group (https://capitalatlas.ai/funds/king-tower-capital-group) — Series C